Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE …
SG Goodman, M Cohen, F Bigonzi, DR Radley… - Journal of the American …, 2000 - jacc.org
OBJECTIVES We sought to determine whether the observed benefits of enoxaparin were
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
[引用][C] Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable Coronary artery disease: One-year results of the …
SG GOODMAN, M COHEN, KAA FOX… - Journal of the …, 2000 - pascal-francis.inist.fr
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin
for unstable Coronary artery disease : One-year results of the ESSENCE study CNRS Inist …
for unstable Coronary artery disease : One-year results of the ESSENCE study CNRS Inist …
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease
SG Goodman, M Cohen, F Bigonzi… - Journal of the American …, 2000 - elibrary.ru
OBJECTIVESWe sought to determine whether the observed benefits of enoxaparin were
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE …
SG Goodman, M Cohen, F Bigonzi… - Journal of the …, 2000 - europepmc.org
Objectives We sought to determine whether the observed benefits of enoxaparin were
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗ A list of participating …
SG Goodman, M Cohen, F Bigonzi, DR Radley… - Journal of the American …, 2000 - infona.pl
OBJECTIVESWe sought to determine whether the observed benefits of enoxaparin were
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
[HTML][HTML] Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: One-year results of the …
SG Goodman, M Cohen, F Bigonzi, DR Radley… - Journal of the American …, 2000 - Elsevier
OBJECTIVES We sought to determine whether the observed benefits of enoxaparin were
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE …
SG Goodman, M Cohen, F Bigonzi… - Journal of the …, 2000 - pubmed.ncbi.nlm.nih.gov
Objectives We sought to determine whether the observed benefits of enoxaparin were
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
[PDF][PDF] Randomized Trial of Low Molecular Weight Heparin (Enoxaparin) Versus Unfractionated Heparin for Unstable Coronary Artery Disease
SG Goodman, M Cohen, F Bigonzi… - Journal of the American …, 2000 - core.ac.uk
OBJECTIVES We sought to determine whether the observed benefits of enoxaparin were
maintained beyond the early phase; a one-year follow-up survey was undertaken for …
maintained beyond the early phase; a one-year follow-up survey was undertaken for …